Personalization of biologic therapy in patients with rheumatoid arthritis: less frequently accounted choice-driving variables

References

• CantiniFNiccoliLNanniniCItalian board for the TAilored BIOlogic therapy (ITABIO). Tailored first-line biologic therapy in patients with rheumatoid arthritis, spondyloarthritis, and psoriatic arthritisSemin Arthritis Rheum20164551953226607440
   PubMed Web of Science ®Google Scholar
• MokCCTsaiWCChenDYWeiJCCImmunogenicity of anti-TNF biologic agents in the treatment of rheumatoid arthritisExpert Opin Biol Ther201616220121126560845
   PubMed Web of Science ®Google Scholar
• MeroniPLValentiniGAyalaFCattaneoAValesiniGNew strategies to address the pharmacodynamics and pharmacokinetics of tumor necrosis factor (TNF) inhibitors: A systematic analysisAutoimmun Rev201514981282925985765
   PubMed Web of Science ®Google Scholar
• GunnGRSealeyDCFJamaliFMeibohmBGhoshSShankarGFrom the bench to clinical practice: understanding the challenges and uncertainties in immunogenicity testing for biopharmaceuticalsClin Exp Immunol2016184213714626597698
   PubMed Web of Science ®Google Scholar
• SethuSGovindappaKAlhaidariMPirmohamedMParkKSathishJImmunogenicity to biologics: mechanisms, prediction and reductionArch Immunol Ther Exp2012605331344
   PubMed Web of Science ®Google Scholar
• JullienDPrinzJCNestleFOImmunogenicity of biotherapy used in psoriasis: the science behind the scenesJ Invest Dermatol20151351313825120005
   PubMed Web of Science ®Google Scholar
• RatanjiKDDerrickJPDearmanRJKimberIImmunogenicity of therapeutic proteins: Influence of aggregationJ Immunotoxicol20141129910923919460
   PubMed Web of Science ®Google Scholar
• GoinsCLChappellCPShashidharamurthyRSelvarajPJacobJImmune complex-mediated enhancement of secondary antibody responsesJ Immunol2010184116293629820439912
   PubMed Web of Science ®Google Scholar
• BatistaFDHarwoodNEThe who, how and where of antigen presentation to B cellsNat Rev Immunol200991152719079135
   PubMed Web of Science ®Google Scholar
• WadhwaMThorpeRStrategies and Assays for the Assessment of Unwanted ImmunogenicityJ Immunotoxicol20063311512118958691
   PubMedGoogle Scholar
• StrandVBalsaAAl-SalehJImmunogenicity of Biologics in Chronic Inflammatory Diseases: A Systematic ReviewBioDrugs201731429931628612180
   PubMed Web of Science ®Google Scholar
• KrieckaertCRispensTWolbinkGImmunogenicity of biological therapeutics: from assay to patientCurr Opin Rheumatol20122430631122388644
   PubMed Web of Science ®Google Scholar
• SchaeverbekeTTruchetetM-EKostineMBarnetcheTBannwarthBRichezCImmunogenicity of biologic agents in rheumatoid arthritis patients: lessons for clinical practiceRheumatology201655221022026268816
   PubMed Web of Science ®Google Scholar
• GarcêsSDemengeotJBenito-GarciaEThe immunogenicity of anti-TNF therapy in immune-mediated inflammatory diseases: a systematic review of the literature with a meta-analysisAnn Rheum Dis201372121947195523223420
   PubMed Web of Science ®Google Scholar
• ManeiroJRSalgadoEGomez-ReinoJJImmunogenicity of Monoclonal Antibodies Against Tumor Necrosis Factor Used in Chronic Immune-Mediated Inflammatory ConditionsJAMA Intern Med2013173151416142823797343
   PubMed Web of Science ®Google Scholar
• ThomasSSBorazanNBarrosoNComparative Immunogenicity of TNF Inhibitors: Impact on Clinical Efficacy and Tolerability in the Management of Autoimmune Diseases. A Systematic Review and Meta-AnalysisBioDrugs201529424125826280210
   PubMed Web of Science ®Google Scholar
• MootsRJXavierRMMokCCThe impact of anti-drug antibodies on drug concentrations and clinical outcomes in rheumatoid arthritis patients treated with adalimumab, etanercept, or infliximab: Results from a multinational, real-world clinical practice, non-interventional studyPLoS One2017124e017520728448562
   PubMed Web of Science ®Google Scholar
• BurmesterGRChoyEKivitzALow immunogenicity of tocilizumab in patients with rheumatoid arthritisAnn Rheum Dis20177661078108528007755
   PubMed Web of Science ®Google Scholar
• BenucciMMeacciFGrossiVCorrelations between immunogenicity, drug levels, and disease activity in an Italian cohort of rheumatoid arthritis patients treated with tocilizumabBiologics201610535827041992
   PubMedGoogle Scholar
• SigauxJHamzeMDaienCImmunogenicity of tocilizumab in patients with rheumatoid arthritisJoint Bone Spine2017841394527369643
   PubMed Web of Science ®Google Scholar
• ListingJGerholdKZinkAThe risk of infections associated with rheumatoid arthritis, with its comorbidity and treatmentRheumatology2013521536123192911
   PubMed Web of Science ®Google Scholar
• MinozziSBonovasSLytrasTRisk of infections using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a systematic review and meta-analysisExpert Opin Drug Saf201615sup1113427924643
   PubMed Web of Science ®Google Scholar
• RoachDRBeanAGDDemangelCFranceMPBriscoeHBrittonWJTNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infectionJ Immunol200216894620462711971010
   PubMed Web of Science ®Google Scholar
• KooSMartyFMBadenLRInfectious Complications Associated with Immunomodulating Biologic AgentsInfect Dis Clin North Am201024228530620466271
   PubMed Web of Science ®Google Scholar
• CantiniFNiccoliLGolettiDTuberculosis Risk in Patients Treated with Non-Anti-Tumor Necrosis Factor- (TNF-) Targeted Biologics and Recently Licensed TNF-Inhibitors: Data from Clinical Trials and National RegistriesJ Rheumatol Suppl201491566424789001
   PubMedGoogle Scholar
• WallisRSBroderMWongJLeeAHoqLReactivation of latent granulomatous infections by infliximabClin Infect Dis200541Supplement_3S194S19815983899
   PubMed Web of Science ®Google Scholar
• TorunerMLoftusEVHarmsenWSRisk factors for opportunistic infections in patients with inflammatory bowel diseaseGastroenterology2008134492993618294633
   PubMed Web of Science ®Google Scholar
• CantiniFBocciaSGolettiDHBV Reactivation in Patients Treated with Antitumor Necrosis Factor-Alpha (TNF-α) Agents for Rheumatic and Dermatologic Conditions: A Systematic Review and Meta-AnalysisInt J Rheumatol20142014292683625114684
   PubMedGoogle Scholar
• StrangfeldAListingJHerzerPRisk of Herpes Zoster in Patients With Rheumatoid Arthritis Treated With Anti–TNF-α AgentsJAMA2009301773774419224750
   PubMed Web of Science ®Google Scholar
• AliTKaithaSMahmoodSFtesiAStoneJBronzeMSClinical use of anti-TNF therapy and increased risk of infectionsDrug Health Patient Saf201357999
   PubMedGoogle Scholar
• AsklingJForedCMBrandtLTime-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonistsAnn Rheum Dis200766101339134417261532
   PubMed Web of Science ®Google Scholar
• WeinblattMESchiffMValenteRHead-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: Findings of a phase IIIb, multinational, prospective, randomized studyArthritis Rheum2013651283823169319
   PubMed Web of Science ®Google Scholar
• ZinkAStrangfeldASchneiderMEffectiveness of tumor necrosis factor inhibitors in rheumatoid arthritis in an observational cohort study: Comparison of patients according to their eligibility for major randomized clinical trialsArthritis Rheum200654113399340717075823
   PubMed Web of Science ®Google Scholar
• AaltonenKJYlikyläSTuulikki JoensuuJEfficacy and effectiveness of tumour necrosis factor inhibitors in the treatment of rheumatoid arthritis in randomized controlled trials and routine clinical practiceRheumatology201756572573528064209
   PubMed Web of Science ®Google Scholar
• SinghJAInfections With Biologics in Rheumatoid Arthritis and Related Conditions: a Scoping Review of Serious or Hospitalized Infections in Observational StudiesCurr Rheumatol Rep201618106127613285
   PubMed Web of Science ®Google Scholar
• RhodesAEvansLEAlhazzaniWSurviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016Intensive Care Med201743330437728101605
   PubMed Web of Science ®Google Scholar
• SingerMDeutschmanCSSeymourCWThe Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)JAMA2016315880181026903338
   PubMed Web of Science ®Google Scholar
• SeymourCWLiuVXIwashynaTJAssessment of Clinical Criteria for Sepsis: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)JAMA2016315876277426903335
   PubMed Web of Science ®Google Scholar
• LauplandKBIncidence of bloodstream infection: a review of population-based studiesClin Microbiol Infect201319649250023398633
   PubMed Web of Science ®Google Scholar
• BuettiNAtkinsonAMarschallJKronenbergASwiss Centre for Antibiotic Resistance (ANRESIS). Incidence of bloodstream infections: a nationwide surveillance of acute care hospitals in Switzerland 2008–2014BMJ Open20177e013665
   PubMed Web of Science ®Google Scholar
• ChandraRKNutrition, immunity and infection: From basic knowledge of dietary manipulation of immune responses to practical application of ameliorating suffering and improving survivalProc Natl Acad Sci U S A1996932514304143078962043
   PubMed Web of Science ®Google Scholar
• Fernandez-MartinezSCortesXBorrás-BlascoJGracia-PérezACasteráMDEEffectiveness of a systematic vaccination program in patients with autoimmune inflammatory disease treated with anti-TNF alpha drugsExpert Opin Biol Ther201616111317132227537179
   PubMed Web of Science ®Google Scholar
• WilliamsELGadolaSEdwardsCJAnti-TNF-induced lupusRheumatology200948771672019416947
   PubMed Web of Science ®Google Scholar
• Pereira VazJLFernandesVNogueiraFArnobioAMLevyRAInfliximab induced autoantibodies. A multicenter studyClin Rheumatol20163532533226676808
   PubMed Web of Science ®Google Scholar
• ChimentiMSSpinelliFRGiuntaAEmergence of antinuclear antibodies in psoriatic patients treated with Infliximab: personal experience and literature reviewDrug Dev Res201475Suppl 1S61S6325381980
   PubMed Web of Science ®Google Scholar
• Ramos-CasalsMBrito-ZerónPSotoM-JCuadradoM-JKhamashtaMAAutoimmune diseases induced by TNF-targeted therapiesBest Pract Res Clin Rheumatol200822584786119028367
   PubMed Web of Science ®Google Scholar
• KatzUZandman-GoddardGDrug-induced lupus: An updateAutoimmun Rev2010101465020656071
   PubMed Web of Science ®Google Scholar
• De BandtMSibiliaJLe LoëtXSystemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national surveyArthritis Res Ther200573R545R55115899041
   PubMed Web of Science ®Google Scholar
• WetterDADavisMDPLupus-Like Syndrome Attributable to Anti – Tumor Necrosis Factor α Therapy in 14 Patients During an 8-Year Period at Mayo ClinicMayo Clin Proc2009841197998419880688
   PubMed Web of Science ®Google Scholar
• CostaMFSaidNRZimmermannBDrug-Induced Lupus due to Anti-Tumor Necrosis Factor α AgentsSemin Arthritis Rheum200837638138717977585
   PubMed Web of Science ®Google Scholar
• VannucchiVGrazziniMPieralliFGiannottaMBiagioniCNozzoliCAdalimumab-induced lupus erythematosus with central nervous system involvement in a patient with Crohn’s diseaseJ Gastrointestin Liver Dis201120220120321725519
   PubMed Web of Science ®Google Scholar
• AringerMSmolenJSTherapeutic blockade of TNF in patients with SLE – Promising or crazy?Autoimmun Rev201211532132521619949
   PubMed Web of Science ®Google Scholar
• MoscaMTaniCFiliceMETNF-alpha inhibitors in Systemic Lupus Erythematosus. A case report and a systematic literature reviewMod Rheumatol201525464264524252029
   PubMed Web of Science ®Google Scholar
• EmerJJFrankelAZeichnerJAA practical approach to monitoring patients on biological agents for the treatment of psoriasisJ Clin Aesthet Dermatol2010382026
   Google Scholar
• DingTLedinghamJLuqmaniRBSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapiesRheumatology201049112217221920837498
   PubMed Web of Science ®Google Scholar
• SinigagliaLNervettiAMelaQA multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid ArthritisJ Rheumatol200027112582258911093437
   PubMed Web of Science ®Google Scholar
• OkanoTInuiKTadaMHigh frequency of vertebral fracture and low bone quality in patients with rheumatoid arthritis – Results from TOMORROW studyMod Rheumatol201727339840427484855
   PubMed Web of Science ®Google Scholar
• SchettGStachCZwerinaJVollRMangerBHow antirheumatic drugs protect joints from damage in rheumatoid arthritisArthritis Rheum200858102936294818821703
   PubMed Web of Science ®Google Scholar
• ShawATGravalleseEMMediators of inflammation and bone remodeling in rheumatic diseaseSemin Cell Dev Biol20164921026481971
   PubMed Web of Science ®Google Scholar
• AmarasekaraDSYuJRhoJBone Loss Triggered by the Cytokine Network in Inflammatory Autoimmune DiseasesJ Immunol Res2015 2015201583212726065006
   PubMed Web of Science ®Google Scholar
• RedlichKSmolenJSInflammatory bone loss: pathogenesis and therapeutic interventionNat Rev Drug Discov201211323425022378270
   PubMed Web of Science ®Google Scholar
• DimitroulasTNikasSNTrontzasPKitasGDBiologic therapies and systemic bone loss in rheumatoid arthritisAutoimmun Rev2013121095896623542506
   PubMed Web of Science ®Google Scholar
• KrieckaertCLMNurmohamedMTWolbinkGLemsWFChanges in bone mineral density during long-term treatment with adalimumab in patients with rheumatoid arthritis: a cohort studyRheumatology201352354755323221326
   PubMed Web of Science ®Google Scholar
• HaugebergGHelgetveitKBFørreØGarenTSommersethHPrøvenAGeneralized bone loss in early rheumatoid arthritis patients followed for ten years in the biologic treatment eraBMC Musculoskelet Disord201415128925182527
   PubMed Web of Science ®Google Scholar
• KawaiVKSteinCMPerrienDSGriffinMREffects of anti-tumor necrosis factor α agents on boneCurr Opin Rheumatol201224557658522810364
   PubMed Web of Science ®Google Scholar
• SiuSHaraouiBBissonnetteRMeta-analysis of tumor necrosis factor inhibitors and glucocorticoids on bone density in rheumatoid arthritis and ankylosing spondylitis trialsArthritis Care Res2015676754764
   PubMed Web of Science ®Google Scholar
• ManaraMSinigagliaLBone and TNF in rheumatoid arthritis: clinical implicationsRMD Open20151Suppl 1e00006526557382
   PubMedGoogle Scholar
• ZerbiniCAFClarkPMendez-SanchezLBiologic therapies and bone loss in rheumatoid arthritisOsteoporos Int201728242944627796445
   PubMed Web of Science ®Google Scholar
• GarneroPThompsonEWoodworthTSmolenJSRapid and sustained improvement in bone and cartilage turnover markers with the anti-interleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: Results from a substudy of the multicenter double-blind, placebo-controlled trial of tocilizumab in inadequate responders to methotrexate aloneArthritis Rheum2010621334320039425
   PubMed Web of Science ®Google Scholar
• KarsdalMASchettGEmeryPIL-6 receptor inhibition positively modulates bone balance in rheumatoid arthritis patients with an inadequate response to anti-tumor necrosis factor therapy: biochemical marker analysis of bone metabolism in the tocilizumab RADIATE study (NCT00106522)Semin Arthritis Rheum201242213113922397953
   PubMed Web of Science ®Google Scholar
• TerposEFragiadakiKKonstaMBratengeierCPapatheodorouASfikakisPPEarly effects of IL-6 receptor inhibition on bone homeostasis: a pilot study in women with rheumatoid arthritisClin Exp Rheumatol201129692192522032557
   PubMed Web of Science ®Google Scholar
• KumeKAmanoKYamadaSThe effect of tocilizumab on bone mineral density in patients with methotrexate-resistant active rheumatoid arthritisRheumatology201453590090324441151
   PubMed Web of Science ®Google Scholar
• BriotKRouanetSSchaeverbekeTThe effect of tocilizumab on bone mineral density, serum levels of Dickkopf-1 and bone remodeling markers in patients with rheumatoid arthritisJoint Bone Spine201582210911525557658
   PubMed Web of Science ®Google Scholar
• BoumansMJHThurlingsRMYeoLRituximab abrogates joint destruction in rheumatoid arthritis by inhibiting osteoclastogenesisAnn Rheum Dis201271110811322072013
   PubMed Web of Science ®Google Scholar
• HeinGEidnerTOelznerPInfluence of Rituximab on markers of bone remodeling in patients with rheumatoid arthritis: a prospective open-label pilot studyRheumatol Int201131226927220661741
   PubMed Web of Science ®Google Scholar
• WheaterGHoganVETengYKOSuppression of bone turnover by B-cell depletion in patients with rheumatoid arthritisOsteoporosis International201122123067307221625887
   PubMed Web of Science ®Google Scholar
• AxmannRHermanSZaissMCTLA-4 directly inhibits osteoclast formationAnn Rheum Dis200867111603160918203760
   PubMed Web of Science ®Google Scholar
• BozecAZaissMMKagwiriaRT cell costimulation molecules CD80/86 inhibit osteoclast differentiation by inducing the IDO/tryptophan pathwaySci Transl Med20146235235ra60
   PubMed Web of Science ®Google Scholar
• CoulsonKAReedGGilliamBEKremerJMPepmuellerPHFactors influencing fracture risk, T score, and management of osteoporosis in patients with rheumatoid arthritis in the Consortium of Rheumatology Researchers of North America (CORRONA) registryJ Clin Rheumatol200915415516019363452
   PubMed Web of Science ®Google Scholar
• KimSYSchneeweissSLiuJSolomonDHEffects of disease-modifying antirheumatic drugs on nonvertebral fracture risk in rheumatoid arthritis: A population-based cohort studyJ Bone Miner Res201227478979622162140
   PubMed Web of Science ®Google Scholar
• RoussyJ-PBessetteLBernatskySRahmeELachaineJBiologic disease-modifying anti-rheumatic drugs and the risk of non-vertebral osteoporotic fractures in patients with rheumatoid arthritis aged 50 years and overOsteoporos Int20132492483249223504029
   PubMed Web of Science ®Google Scholar
• KawaiVKGrijalvaCGArbogastPGInitiation of tumor necrosis factor α antagonists and risk of fractures in patients with selected rheumatic and autoimmune diseasesArthritis Care Res201365710851094
   PubMed Web of Science ®Google Scholar
• KässerURGleissnerCDehneFMichelAWillershausen-ZönnchenBBoltenWWRisk for periodontal disease in patients with longstanding rheumatoid arthritisArthritis Rheum19974012224822519416864
   PubMed Web of Science ®Google Scholar
• MercadoFBMarshallRIKlestovACBartoldPMRelationship Between Rheumatoid Arthritis and PeriodontitisJ Periodontol200172677978711453241
   PubMed Web of Science ®Google Scholar
• PischonNPischonTKrögerJAssociation among rheumatoid arthritis, oral hygiene, and periodontitisJ Periodontol200879697998618533773
   PubMed Web of Science ®Google Scholar
• GaribBTQaradaxiSSTemporomandibular joint problems and periodontal condition in rheumatoid arthritis patients in relation to their rheumatologic statusJ Oral Maxillofac Surg201169122971297821764200
   PubMed Web of Science ®Google Scholar
• SmitMWestraJVissinkADoornbosvan der MeerBBrouwerEvan WinkelhoffAPeriodontitis in established rheumatoid arthritis patients: a cross-sectional clinical, microbiological and serological studyArthritis Res Ther2012145R22223075462
   PubMed Web of Science ®Google Scholar
• ScherJUUbedaCEquindaMPeriodontal disease and the oral microbiota in new-onset rheumatoid arthritisArthritis Rheum201264103083309422576262
   PubMed Web of Science ®Google Scholar
• PotikuriDDannanaKCKanchinadamSPeriodontal disease is significantly higher in non-smoking treatment-naive rheumatoid arthritis patients: results from a case-control studyAnn Rheum Dis20127191541154422875903
   PubMed Web of Science ®Google Scholar
• JosephRRajappanSNathSGPaulBJAssociation between chronic periodontitis and rheumatoid arthritis: a hospital-based case–control studyRheumatol Int201333110310922228465
   PubMed Web of Science ®Google Scholar
• MikulsTRPayneJBYuFPeriodontitis and Porphyromonas gingivalis in Patients With Rheumatoid ArthritisArthritis Rheumatol20146651090110024782175
   PubMed Web of Science ®Google Scholar
• ArkemaEVKarlsonEWCostenbaderKHA prospective study of periodontal disease and risk of rheumatoid arthritisJ Rheumatol20103791800180420595268
   PubMed Web of Science ®Google Scholar
• DemmerRTMolitorJAJacobsDRMichalowiczBSPeriodontal disease, tooth loss and incident rheumatoid arthritis: results from the First National Health and Nutrition Examination Survey and its epidemio-logical follow-up studyJ Clin Periodontol20113811998100622092471
   PubMed Web of Science ®Google Scholar
• ErikssonKNiseLKatsAPrevalence of Periodontitis in Patients with Established Rheumatoid Arthritis: A Swedish Population Based Case-Control StudyPLoS One2016115e015595627203435
   PubMed Web of Science ®Google Scholar
• WolffBBergerTFreseCOral status in patients with early rheumatoid arthritis: a prospective, case-control studyRheumatology201453352653124273047
   PubMed Web of Science ®Google Scholar
• JavedFAhmedHBMikamiTAlmasKRomanosGEAl-HezaimiKCytokine profile in the gingival crevicular fluid of rheumatoid arthritis patients with chronic periodontitisJ Investig Clin Dent20145118
   Google Scholar
• ScherJUBretzWAAbramsonSBPeriodontal disease and subgingival microbiota as contributors for rheumatoid arthritis pathogenesisCurr Opin Rheumatol201426442442924807405
   PubMed Web of Science ®Google Scholar
• BruscaSBAbramsonSBScherJUMicrobiome and mucosal inflammation as extra-articular triggers for rheumatoid arthritis and autoimmunityCurr Opin Rheumatol201426110110724247114
   PubMed Web of Science ®Google Scholar
• AlgoodHMLinPLYankuraDJonesAChanJFlynnJLTNF influences chemokine expression of macrophages in vitro and that of CD11b+ cells in vivo during Mycobacterium tuberculosis infectionJ Immunol2004172116846685715153503
   PubMed Web of Science ®Google Scholar
• AraújoVMAMeloIMLimaVRelationship between Periodontitis and Rheumatoid Arthritis: Review of the LiteratureMediators Inflamm2015201525907426347200
   PubMed Web of Science ®Google Scholar
• SavioliCRibeiroACFabriGMPersistent periodontal disease hampers anti-tumor necrosis factor treatment response in rheumatoid arthritisJ Clin Rheumatol201218418018422647860
   PubMed Web of Science ®Google Scholar
• ChenHHChenDYLaiKLPeriodontitis and etanercept discontinuation risk in anti-tumor necrosis factor-naive rheumatoid arthritis patients: a nationwide population-based cohort studyJ Clin Rheumatol201319843243824263145
   PubMed Web of Science ®Google Scholar
• OrtizPBissadaNFPalomoLPeriodontal therapy reduces the severity of active rheumatoid arthritis in patients treated with or without tumor necrosis factor inhibitorsJ Periodontol200980453554019335072
   PubMed Web of Science ®Google Scholar
• BıyıkoğluBBuduneliNAksuKPeriodontal therapy in chronic periodontitis lowers gingival crevicular fluid interleukin-1beta and DAS28 in rheumatoid arthritis patientsRheumatol Int201333102607261623728274
   PubMed Web of Science ®Google Scholar
• ErciyasKSezerUUstünKEffects of periodontal therapy on disease activity and systemic inflammation in rheumatoid arthritis patientsOral Dis201319439440022998534
   PubMed Web of Science ®Google Scholar
• OkadaMKobayashiTItoSPeriodontal treatment decreases levels of antibodies to Porphyromonas gingivalis and citrulline in patients with rheumatoid arthritis and periodontitisJ Periodontol20138412e74e8423701010
   PubMed Web of Science ®Google Scholar
• MayerYElimelechRBalbir-GurmanABraun-MoscoviciYMachteiEEPeriodontal condition of patients with autoimmune diseases and the effect of anti-tumor necrosis factor-α therapyJ Periodontol201384213614222524332
   PubMed Web of Science ®Google Scholar
• KadkhodaZAmirzargarAEsmailiZVojdanianMAkbariSEffect of TNF-α Blockade in Gingival Crevicular Fluid on Periodontal Condition of Patients with Rheumatoid ArthritisIran J Immunol201613319720327671511
   PubMed Web of Science ®Google Scholar
• KobayashiTYokoyamaTItoSPeriodontal and serum protein profiles in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitor adalimumabJ Periodontol201485111480148824857321
   PubMed Web of Science ®Google Scholar
• HanJYReynoldsMAEffect of anti-rheumatic agents on periodontal parameters and biomarkers of inflammation: a systematic review and meta-analysisJ Periodontal Implant Sci201242131222413068
   PubMed Web of Science ®Google Scholar
• FabriGMPereiraRMSavioliCPeriodontitis Response to Anti-TNF Therapy in Ankylosing SpondylitisJ Clin Rheumatol201521734134526398459
   PubMed Web of Science ®Google Scholar
• MatchamFRaynerLSteerSHotopfMThe prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysisRheumatology201352122136214824003249
   PubMed Web of Science ®Google Scholar
• OstensenMRheumatoid arthritis: The effect of RA and medication on female fertilityNat Rev Rheumatol201410951851925003768
   PubMed Web of Science ®Google Scholar
• BrouwerJFleurbaaijRHazesJMWDolhainRLavenJSESub-fertility in Women With Rheumatoid Arthritis and the Outcome of Fertility AssessmentsArthritis Care Res201769811421149
   PubMed Web of Science ®Google Scholar
• CostaTFSilvaCRMunizLFMotaLMPrevalence of sexual dysfunction among female patients followed in a Brasília Cohort of early rheumatoid arthritisRev Bras Reumatol201555212313225559062
   PubMedGoogle Scholar
• BrouwerJHazesJMLavenJSDolhainRJFertility in women with rheumatoid arthritis: influence of disease activity and medicationAnn Rheum Dis201574101836184124833784
   PubMed Web of Science ®Google Scholar
• GordonDBeastallGHThomsonJASturrockRDAndrogenic status and sexual function in males with rheumatoid arthritis and ankylosing spondylitisQ J Med1986602316716793094090
   PubMedGoogle Scholar
• CutoloMBalleariEGiustiMMonachesiMAccardoSSex hormone status of male patients with rheumatoid arthritis: evidence of low serum concentrations of testosterone at baseline and after human chorionic gonadotropin stimulation. Sex hormone status of male patients with rheumatoid arthritis: evidence of low serum concentrations of testosterone at baseline and after human chorionic gonadotropin stimulationArthritis Rheum198831131413173140823
   PubMed Web of Science ®Google Scholar
• LeroyCRigotJMLeroyMImmunosuppressive drugs and fertilityOrphanet J Rare Dis20151013626490561
   PubMed Web of Science ®Google Scholar
• GutierrezJCHwangKThe toxicity of methotrexate in male fertility and paternal teratogenicityExpert Opin Drug Metab Toxicol2017131515827590039
   PubMed Web of Science ®Google Scholar
• RamondaRForestaCOrtolanAInfluence of tumor necrosis factor α inhibitors on testicular function and semen in spondyloarthritis patientsFertil Steril2014101235936524332378
   PubMed Web of Science ®Google Scholar
• OhJSHeoHMKimYGLeeSGLeeCKYooBThe effect of anti-tumor necrosis factor agents on sexual dysfunction in male patients with ankylosing spondylitis: a pilot studyInt J Impot Res200921637237519759542
   PubMed Web of Science ®Google Scholar
• SmolenJSLandewéRBijlsmaJEULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 updateAnn Rheum Dis201776696097728264816
   PubMed Web of Science ®Google Scholar
• SinghJASaagKGBridgesSL2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid ArthritisArthritis Rheumatol2016681126
   PubMed Web of Science ®Google Scholar
• TarpSEric FurstDBoersMRisk of serious adverse effects of biological and targeted drugs in patients with rheumatoid arthritis: a systematic review meta-analysisRheumatology201756341742528013201
   PubMed Web of Science ®Google Scholar
• AtkinsDBestDBrissPAGrading quality of evidence and strength of recommendationsBMJ20043287454149015205295
   PubMed Web of Science ®Google Scholar
• CantiniFNiccoliLNanniniCSecond-line biologic therapy optimization in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitisSemin Arthritis Rheum201747218319228413099
   PubMed Web of Science ®Google Scholar
• FavalliEGRaimondoMGBeccioliniACrottiCBiggioggeroMCaporaliRThe management of first-line biologic therapy failures in rheumatoid arthritis: Current practice and future perspectivesAutoimmun Rev201716121185119529037899
   PubMed Web of Science ®Google Scholar